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of the Boston Scientific algorithm by reviewing PMT episodes in a large device population.
Methods: In this multicenter study, we included 328 patients implanted with a Boston Scientific
device: 157 non-dependent patients with RYTHMIQ™ activated (RYTHMIQ group), 76 patients
with permanent AV-conduction disorder (AV-block group) and 95 Cardiac Resynchronization
Therapy patients (CRT group). For each patient, we reviewed the last 10 remote monitoring-
transmitted EGMs diagnosed as PMT.
Results:We analyzed 784 PMT episodes across 118 patients. In the RYTHMIQ group, the diagnosis
of PMT was correct in most episodes (80%) of which 69% was directly related to the prolongation of
the AV-delay associated with the RYTHMIQ algorithm. The usual triggers for PMT were also
observed (PVC 16%, PAC 9%). The remainder of the episodes (20%) in RYTHMIQ patients and
most episodes of AV-block (66%) and CRT patients (74%) were incorrectly diagnosed as PMT
during sinus tachycardia at the maximal tracking rate. The inappropriate intervention of the
algorithm during exercise causes non-conducted P-waves, loss of CRT (sustained in six patients) and
may have been pro-arrhythmogenic in one patient (induction of ventricular tachycardia).
Conclusion: Algorithms to minimize ventricular pacing can occasionally have unintended
consequences such as PMT. The PMT algorithm in Boston Scientific devices is associated with a
high rate of incorrect PMT diagnosis during exercise resulting in inappropriate therapy with non-
conducted P-waves, loss of CRT and limited risk of pro-arrhythmic events.
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Pacemaker mediated tachycardia (PMT) describes a
repetitive sequence of sensed retrograde atrial events
followed by ventricular pacing. This phenomenon has been
observed and understood early after the introduction of
dual-chamber pacing in patients presenting with intrinsic
ventriculo-atrial (VA) conduction [1–3]. The majority of
patients are asymptomatic but patients may report symptomsrticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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syncope, or chest discomfort. Prolonged PMT may be poorly
tolerated or even lead to cardiac decompensation in patients
suffering from underlying heart disease [4].
The incidence of PMT varies as a function of patient
characteristics, programming of the device and the specific-
ities of the algorithms provided by the manufacturers [4].
While many isolated clinical cases of PMT have been
described, there is few data on the incidence of PMT across
pacemaker and defibrillator recipients [5–9]. Depending on
the manufacturer, one must understand the specific means of
prevention, diagnosis and termination of PMT in order to
optimize the management of device recipients. Each device
manufacturer has a proprietary algorithm to detect and
terminate PMT, with a large proportion of similarities,
including the phases of suspicion, confirmation and
termination. Studies to compare the respective effectiveness
of these various algorithms of detection and termination of
PMT are non-existent. In Boston Scientific devices, episodes
of PMT are recorded in the memory. The ability to view the
electrograms enables identifying and resolving the trigger of
the tachycardia but also offers the opportunity to assess the
frequency of this problem. Recently, we observed that their
AV Search+ algorithm, which increases the atrioventricular
delay in search for intrinsic conduction, was associated with
PMT induction in a selected group of patients [10]. In the
present study, we assessed the diagnostic and therapeutic
efficacy of the PMT algorithm by reviewing EGMs of PMT
episodes in a large population of implanted patients.Methods
In this multicenter study, we included 337 patients
implanted with a Boston Scientific device across four
French centers. We distinguished 3 groups: 157 patients
with a dual chamber device, without permanent AV
conduction disorder and with the RYTHMIQ™ algorithm
activated (RYTHMIQ group), 76 patients with a dual
chamber device, permanent AV conduction disorder and
RYTHMIQ™ algorithm not-activated (AV-block group)
and 95 patients with a triple-chamber Cardiac Resynchro-
nization Therapy device (CRT group). To be enrolled,
patients needed to be programmed in AAI with VVI Backup
(RYTHMIQ group) or DDD(R) mode (AV-block and CRT
groups). When available, we reviewed the last 10 remote
monitoring-transmitted EGMs labeled PMT with focus on
determining the specificity of the algorithm and the etiology
of the events. All patients gave written, informed consent
for analysis of the data providing from remote monitoring
and patient information was de-identified prior to analysis of
the episodes.
Description of the anti-PMT algorithm
Boston Scientific devices label and save an episode as
PMT when two criteria are met.
1. Sixteen consecutive ventricular pace (VP) and atrial
sense (AS) cycles occur at the programmed maximumtracking rate. Default value of 130 beats per minute
(coupling interval of 430 ms).
2. The variance between ventriculo-atrial intervals does
not exceed 32 ms.
There exists no confirmation phase in Boston Scientific
devices. Directly after diagnosis of PMT, the algorithm
executes an automatic lengthening of the PVARP to 500 ms
following the 16th cycle for a single cycle.
RYTHMIQ algorithm with AV search+
The RYTHMIQ™ algorithm, implemented in Boston
Scientific dual-chamber pacemakers and implantable cardi-
overter-defibrillators, is designed to minimize ventricular
pacing by favoring intrinsic ventricular conduction in
non-pacemaker dependent patients. When RYTHMIQ is
activated, the device operates in AAI(R) mode with VVI
back-up. RYTHMIQ executes a mode switch to DDD(R)
mode when AV-conduction disorder is suspected. In
DDD(R) mode, the algorithm uses the AV Search+™ to
periodically check for return of intrinsic conduction. After a
certain number of cardiac cycles in DDD mode (default
value at 32 cycles), the AV Search Interval is activated and
the AV delay is extended to the programmed AV Search+™
value (default value: 300 ms). If a V-sense is detected within
the 8 cycles period of AV Search+™, hysteresis continues.
The AV Conduction Detector Counter is initialized at “0”
and is incremented by each ventricular sensed event (marked
as VS-Hy). When the AV Conduction Counter has reached
25, sustained conduction is detected and the device switches
back to the primary AAI(R) mode with VVI back-up. The
device maintains DDD(R) mode and does not switch back to
the AAI(R) mode when no intrinsic conduction is detected
within the first 8 cycles search period or when two out of the
last 10 ventricular events are paced (sliding window).
Statistics
Continuous variables were expressed as median [min–
max] and categorical variables were expressed as absolute
numbers (percentages). Differences in baseline characteris-
tics between groups were evaluated with the use of the
Kruskal–Wallis H test for continuous data and Pearson's
chi-square test for categorical data. Statistical significance
was assumed at p b 0.05. Statistical analyses were per-
formed using SPSS version 18.0 (SPSS Inc., Chicago, IL).Results
Demographics and device programming
Patient demographics and device specifications are
specified per group in Table 1. All CRT patients were
equipped with ICDs while 17% of AV-block patients and
25% of RYTHMIQ patients were pacemaker recipients
(P b 0.001 for comparison between three groups). CRT and
AV block patients had a median cumulative ventricular
pacing percentage of 99%, while RYTHMIQ patients had
only a median of 1% cumulative ventricular pacing
(P b 0.001 for comparison between three groups). The
Table 1
Demographics and device specifications of patients with dual chamber Boston Scientific devices divided in three groups according to underlying etiology
Categorical variables are expressed as absolute numbers (percentages), continuous variables are expressed as median [min–max].
RYTHMIQ AV-block CRT P-value
Patient demographics n = 157 n = 76 n = 95
Age [years] 68 [23–95] 75 [1–96] 68 [44–89] b0.001
Male sex [n] 101 (64%) 49 (65%) 70 (74%) 0.319
Device type
Pacemaker [n] 40 (25%) 63 (17%) 0 (0%) b0.001
ICD [n] 117 (75%) 13 (83%) 105 (100%)
Device programming
Lower rate limit [bpm] 55 [35–80] 60 [40–80] 60 [40–70] b0.001
Maximal tracking rate [bpm] 130 [100–155] 130 [110–170] 130 [110–160] 0.172
Minimum sensed AV delay [ms] 65 [60–220] 65 [50–220] 100 [55–200] b0.001
Maximum sensed AV delay [ms] 150 [100–350] 150 [80–340] 120 [70–200] b0.001
Minimum paced AV delay [ms] 80 [80–220] 80 [50–220] 140 [80–200] b0.001
Maximum paced AV delay [ms] 180 [150–350] 180 [80–340] 160 [100–300] b0.001
Device output
Percentage ventricular pacing [%] 1 [0–100] 99 [0–100] 99 [0–100] b0.001
Percentage atrial pacing [%] 18 [0–100] 25 [0–100] 8 [0–100] 0.023
Median respiratory rate [per min] 16 [11–26] 16 [11–23] 17 [11–26] 0.090
Activity level [% of day] 7 [0–50] 7 [0–28] 9 [0–35] 0.056
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three groups (P = NS).
Anti-PMT algorithm performance
118 patients had at least one PMT episode with a median
of 40 episodes per patient. Out of all 46.375 PMT episodes,
we analyzed 784 EGMs. An overview of the anti-PMT
algorithm performance is shown in Table 2. In the
RYTHMIQ group, the diagnosis of PMT was correct in
the majority of episodes (124/154) which resulted in a
specificity of 80%. The usually reported triggers for PMT
such as premature atrial contractions (PACs) and premature
ventricular contractions (PVCs) were together responsible
for less than one-third of PMT episodes (PAC 11% and PVC
20%). An example of PMT triggered by PAC is shown in
Fig. 1 (EGM and schematic) while Fig. 2 shows PMT
induced by two consecutive PVCs. In the majority (69%) of
correctly diagnosed PMT episodes, the onset of PMT was
directly related to the prolongation of the AV delay
associated with the AV Search+ protocol (as part of the
RYTHMIQ™ algorithm). Fig. 3 shows an example of PMT
in the context of AV hysteresis during AV Search+. ThisTable 2
Diagnostic overview of the PMT algorithm for the three patient groups. When available, up to 10 PMT episodes were analyzed per patient. Categorical variable
are expressed as absolute numbers (percentages). PVC: premature ventricular contraction. PAC premature atrial contraction.
RYTHMIQ
n = 156
AV-block
n = 76
CRT
n = 95
P-value
Patients with PMT episodes 27 (17%) 30 (39%) 61 (64%) b0.001
Total amount of PMT episodes 13.379 18.699 14.297
PMT episodes analyzed 154 214 416
Incorrect PMT diagnosis 30 (20%) 142 (66%) 306 (74%) b0.001
Correct PMT diagnosis 124 (80%) 72 (44%) 110 (26%)
PAC [n, % of correct] 14 (11%) 54 (82%) 32 (29%) b0.001
PVC [n, % of correct] 25 (20%) 12 (18%) 64 (58%) b0.001
RYTHMIQ [n, % of correct] 85 (69%) – –.algorithm may be on its own responsible for the PMT
induction but the risk is increased when premature atrial or
ventricular contractions occur during AV hysteresis.
The algorithm incorrectly labeled PMT in 20% of cases in
response to normal tracking of intrinsic atrial events at the
maximal tracking rate during sinus tachycardia. This occurs
in patients where RYTHMIQ previously executed a mode
switch from AAI to DDD mode so that atrial sensed events
trigger ventricular pacing, a required component for PMT.
Fig. 4 shows an example of a patient in sinus tachycardia at
maximal tracking rate where PMT was incorrectly diagnosed
by the device and which results in a non-conducted P-wave
due to the extension of the PVARP after the 16th cycle. In
the other patient groups (AV block group and CRT group),
the incorrect diagnosis of PMT during sinus tachycardia at
maximal tracking rate was responsible for the majority of
episodes (66% and 74%, respectively). The correctly
diagnosed PMT episodes (specificity of 44% in AV-block
patients and 26% in CRT patients) occurred in the context of
premature atrial or ventricular contractions. In dependent
patients (AV block group) incorrect PMT labeling resulted
into an inappropriate PVARP extension and therefore in
non-conducted P-waves while in non-dependent CRTs
Fig. 1. Example of pacemaker-mediated tachycardia in the context of premature atrial contraction. [1] A premature atrial contraction (PAC) triggers a ventricula
pace at the maximal tracking rate (VP-MT). [2] The triggered VP results in retrograde V-A conduction which is sensed as a PAC and on its turn, again triggers a
VP (PMT). [3] PMT is diagnosed after 16 stable VP-AS at maximal tracking rate. [4] After the 16th VP-MT, the PVARP is extended to 500 ms which terminates
the PMT.
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ventricular conduction and therefore loss of resynchroniza-
tion therapy. We have also observed a certain number of
phenomena which were less frequent. In the CRT group,
inappropriate intervention of the algorithm during exercise
was associated with sustained interruption of biventricular
pacing in 6 patients. In these patients having sinus
tachycardia and with prolonged PR intervals, the interven-
tion (extension of PVARP) resulted in an intrinsic ventricular
beat where due to the left bundle branch block the RV sense
was also delayed so the succeeding sinoatrial event occurred
during the following PVARP. Fig. 5 shows an example
where this sequence of sinoatrial events occurring in the
PVARP of the preceding intrinsic ventricular events causedFig. 2. Example of pacemaker-mediated tachycardia in the context of premature ventricular contraction (PVC). [1] The first PVC occurs simultaneously with a
sinoatrial event, the refractory AV node inhibits retrograde (V-A) conduction. [2] However, the second PVC initiates retrograde conduction which results in AS
and an AV delay for BIV stimulation. The RV is stimulated at the maximal tracking rate while LV stimulation is inhibited (Inh-LVP) since it is too soon after the
preceding LVS. [3] After PMT diagnosis, [4] a single prolongation of the PVARP to 500 ms terminates the PMT.rextended loss of CRT. In one patient, the inappropriate
intervention of the algorithmmay have been pro-arrhythmogenic.
Fig. 6 shows that directly after the PVARP extension a
ventricular tachycardia (VT) is initiated. This patient was
equipped with an ICD and the VT was treated with
anti-tachycardia pacing. While three burst treatments were
ineffective, a ramp treatment succeeded into VT termination.Discussion
PMT remains a common phenomenon among patients
with cardiac stimulation devices. This study permits us to
draw important conclusions about PMT in general and about
the specificities of the Boston Scientific algorithm.
Fig. 3. Example of pacemaker-mediated tachycardia in the context of AV Search+™ (RYTHMIQ™). [1] During AV Search+, the AV delay is extended to
search for intrinsic ventricular conduction (marked as VS-Hy). [2] After the third VS-Hy, intrinsic conduction is too slow which triggers a VP. After 2 VPs in a
sliding window of 10 the AV Search+ protocol is terminated and the device returns to DDD mode. However, because there is AV block and a prolonged AV
delay, the AV-node has recovered by the time the ventricular stimulus occurs enabling retrograde V-A conduction and the ventricle is stimulated at maxima
tracking rate (VP-MT). [3] The electronic re-entry is sustained until the pacemaker correctly labels the event as PMT (16 cycles of VP-MT) and increases the
post-ventricular atrial refractory period (PVARP) to 500 ms for one cycle which terminates the PMT. [4] Since the AV Search+ phase was terminated
ventricular pacing continues at short AV delay.
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The heterogeneous performance of the Boston Scientific
anti-PMT algorithm between patient groups indicates that its
accuracy is highly dependent on underlying patient etiology.
The overall specificity of the anti-PMT algorithm is low
(39%) which is caused by incorrect diagnosis of PMT during
sinus tachycardia at the maximal tracking rate, especially in
patients with a disabled RYTHMIQ algorithm (AV-block
group and CRT group). Even though sinus tachycardia at
exactly the maximal tracking rate (with variance of at most a
few milliseconds) seems to be an unlikely event and the
overall incidence of sinus tachycardia is unknown, the sheerFig. 4. Incorrectly labeled ‘PMT’ episode in the context of sinus tachycardia at maximal tracking rate. [1] Atrial sensing during sinus tachycardia close to the
maximal tracking rate (≈150 bpm). [1] When the atrial coupling interval is just above maximal tracking (403 ms N 400 ms), a regular VP resets the PMT
counter (0/16). [3] Sixteen atrial events at (or slightly faster than) maximal tracking trigger sixteen VP-MT-AS which establishes the diagnosis of ‘PMT’. [4] Like
all PMTs, the 16th VP-MT is followed by a PVARP extension to 500 ms during which a true atrial sense occurs which is not followed by a ventricula
stimulation (non-conducted P-wave).l
,number of episodes we found with this issue (478) actually
reveals it is quite a common trigger. The other 306 episodes
were ‘true’ PMTs (correctly diagnosed) which were associated
with premature atrial contractions (especially in the AV block
group), premature ventricular complexes (especially in the
CRT group) and surprisingly by the RYTHMIQ algorithm
(exclusively in the RYTHMIQ group).
AV Search+
The AV Search+ protocol is part of the RYTHMIQ
algorithm which aims to lower the ventricular pacing burden
by favoring intrinsic conduction. During AV hysteresis (orr
Fig. 5. Example of loss of biventricular stimulation in the context of inappropriate PMT therapy. [1] Patient is in sinus tachycardia which approximates maxima
tracking rate. [2] After sixteen sequences of VP-MT-AS the device inappropriately declares PMT. [3] The PMT algorithm results in extension of the PVARP to
500 ms during a single cycle which induces intrinsic ventricular conduction with a relatively long PR interval. [4] Since atrial coupling cycle is short and PR
interval is long, every atrial event occurs during the PVARP which induced extended period of loss of biventricular stimulation.
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intrinsic ventricular events follow atrial events. In some
patients, intermittent AV block and a prolonged AV delay
permit recovery of the AV refractory period which enables
retrograde VA conduction. The possibility of retrograde VA
conduction due to a long AV delay may be present at only
certain moments of time. Previously, a case report has
described the occurrence of PMT associated with this type of
algorithm (St. Jude Medical) [11].
We report here the initiation of pacemaker-mediated
tachycardia (PMT) by the normal function of a RYTHMIQ
AV Search+ algorithm in a large number of patients. This
study demonstrates that the link between a prolonged AV
delay and initiation of PMT is not rare and was previously
underreported. The extension of the AV delay on its own
may initiate a PMT (such as shown in Fig. 3) but a
combination with a PAC or PVC, which derails atrial and
ventricular activation, is also a possible trigger of PMT. The
high rate of patients with enabled RYTHMIQ™ and PMT
exposes the weakness of using this type of algorithm. Other
algorithms do not search for spontaneous conduction by
extending the AV delay but rather perform a direct mode
switch to AAI (Sorin and Medtronic). This decreases the risk
of PMTs while the risk of non-conducted P waves is
increased which can be symptomatic in some patients.
During DDD mode the AV Search+™ algorithm searches
for spontaneous conduction every 32 beats. Progressively
increasing this amount may considerably reduce the amount
of PMTs. Of important note, after disabling the RYTHMIQ
algorithm, the AV Search+™ algorithm remains active and
needs to be manually disabled. When not switched off, AVlSearch+™will continue to search every 32 beats, even when
in permanent DDD mode.
Loss of resynchronization by the ant-PMT algorithm
For a good response to CRT, sustained and adequate
biventricular stimulation is imperative [12,13]. The function
of a CRT device during a heart rate above the maximal
tracking rate depends on the quality of the AV-conduction of
the patient. In a resynchronized patient with complete
AV-block and preserved chronotropic capacity, a Wenck-
ebach phenomenon occurs when the sinoatrial rate acceler-
ates above the maximal tracking rate. When the sinoatrial
rate accelerates above the maximal tracking rate in a
resynchronized patient with preserved AV conduction and
good chronotropic capacity, the intrinsic activation wave
front will dominate ventricular activation and ventricular
stimulation is interrupted. In both cases, biventricular
stimulation will be re-initiated when the heart rate falls
below the maximal tracking rate. However, our study does
reveal certain cases of prolonged loss of biventricular
stimulation in patients with prolonged intrinsic PR-intervals.
The intervention during sinus tachycardia by the PMT
algorithm causes a non-conducted P-wave (since the atrial
sense occurs within the PVARP) followed by an intrinsic
ventricular beat. During exercise, the RP interval is short
which increases the risk of the following atrial event to again
occur during the PVARP, even though the PVARP is
shortened automatically. This phenomenon can result in
sustained loss of biventricular stimulation even when the
sinoatrial rate falls below the maximal tracking rate. As long
Fig. 6. Example of ventricular tachycardia in the context of inappropriate PMT treatment. [1] Sinus tachycardia at maximal tracking rate, [2] after 16 beats o
RVP-MT-AS the device classifies PMT and [3] for a single cycle, the PVARP is extended to 500 ms. [4] After an intrinsic ventricular event (ventricula
stimulation is inhibited since the atrial sense occurs during the PVARP) and a stimulated right ventricular event (inhibition of left ventricular pacing), a
monomorphic ventricular tachycardia arises. [5] After 8 intervals in the VT zone, the ICD detects the tachycardia and labels “V-Epsd” with criteria of sudden
onset (“Suddn”).
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stimulation will be withheld. Resynchronized patients with
long PR-interval need careful programming of the maximal
tracking rate and consideration of disabling the anti-PMT
algorithm.
Possible arrhythmogenesis
The “short-long-short” ventricular sequence is a well-
known phenomenon responsible for the initiation of
polymorphic ventricular arrhythmias in long QT syndromes
and monomorphic VTs in ICD patients. A case report in the
context of a similar device model has previously shown the
development of a VT after an inappropriate intervention by
the anti-PMT algorithm during sinus tachycardia [14]. The
combination of exercise, release of catecholamines and the
short-long-short sequence is the probable responsible factors
for the induction of the arrhythmias described in the report
and in our study. This is the first study that provides data to
assess the frequency of the problem. Since inappropriate
intervention during sinus tachycardia is common, and we
only observed one patient with an associated VT, one may
consider it a rare problem. VT induction in pacemaker
patient may be more dangerous than in a defibrillator patient,
even though their arrhythmogenic risk would probably be
lower. To avoid recurrence, it is essential to raise the
maximal tracking rate which decreases the risk of inappro-
priate intervention by the algorithm during sinus tachycardia.
Non-detection of PMT under the maximal tracking rate
The heart rate during PMT depends on a combination of
the retrograde conduction time, the programmed maximumf
rrate and the AV delay. An important note is that PMTs below
the maximum tracking rate will not meet Boston Scientific's
algorithm criteria for PMT, will therefore not be saved to the
memory as an episode and will not be treated. This causes
difficulties in programming the maximal tracking rate since
patients with relatively prolonged retrograde V-A conduc-
tion risk developing relatively slow PMTs which will not be
diagnosed by the device when the maximal tracking rate is
programmed too high. The optimal setting of this parameter
must, therefore, strike a balance between the needs of the
patient with respect to 1:1 tracking to prevent a Wenckebach
periodicity during effort (need to program a high maximal
tracking rate) on the one hand, and the risk of non-detection
and termination of a PMT (need to program a low maximal
tracking rate) on the other hand.Specificities of the Boston Scientific algorithm
This study is only made possible because a sequence of
events classified as PMT is saved into the memory of the
device. This is also the case for St. Jude Medical devices but
not for Medtronic, Biotronik and Sorin devices. A definite
comparison of the PMT algorithms between pacemaker
manufacturers is not possible and the results cannot be
extended to other algorithms but there are some observations
to be made. For the suspicion phase, 8 consecutive AS-VP
cycles are required for the devices of all the manufacturers,
except for Boston Scientific, which requires 16 cycles,
causing a slight delay in the diagnosis and a prolongation of
the episodes. During suspicion only the criteria of stability
between V-A intervals needs to be met, there is no
confirmation phase such as modification of the AV delay
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and PMT. This explains the low specificity in stimulated
patients (dependent or resynchronized patients) with the risk
of at least one non-conducted P wave in dependent patients
or loss of resynchronization in CRT patients. The algorithms
of Biotronik, Saint Jude Medical and Sorin devices are
included with a confirmation phase with modulation of the
AV delay and analysis of the following VP-AS interval,
which limits the risk of intervention for sinus tachycardia
during exercise. Saint-Jude Medical also relies on AV
hysteresis to search for intrinsic conduction which is a
potential trigger for PMT.Limitations
This study has several limitations, namely the retrospective
nature of the analysis and the limited proportion of PMT
episodes with stored EGMs (in relation to the total number of
PMT episodes). Nevertheless, based on the large amount of
episodes we can conclude that the specificity of the algorithm
is low. Calculating the sensitivity was not possible since we
were not able to investigate PMTs which did not trigger the
algorithm to diagnose PMT and save the episode to the device.Conclusion
Algorithms to minimize ventricular pacing can occasion-
ally have unintended consequences such as PMT. In Boston
Scientific devices, the absence of confirmation phase leads to
a high rate of incorrect diagnosis of PMT during exercise
resulting in non-conducted P waves and loss of biventricular
stimulation. The pro-arrhythmogenic risk (long–short cycle)
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